Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Next Hurdles For COVID-19 Vaccine Development: Selecting Endpoints, Getting Enough Subjects

Jun 11 2020

• By Brenda Sandburg

COVID-19 Vaccine. Corona Virus SARS-CoV-2, 2019 nCoV virus destruction. A vaccine against coronavirus disease 2019. Breakthrough in the Creating of a COVID-19 Vaccine. — COVID-19 vaccine candidates face new challenges as they move into Phase 2/3 trials

Related Content

US FDA Looking To Real-World Evidence To Fill in Gaps On COVID-19 Vaccines

Jun 12 2020

NIH Partnership To Pick COVID-19 Therapeutics For Clinical Trials; Results Anticipated By Summer

Apr 19 2020

COVID-19: The Race To Develop A Vaccine

Jun 09 2020

Related Companies

Novavax, Inc.

Johnson & Johnson

Additional Topics

Coronavirus COVID-19 Vaccines Clinical Trials FDA Policy BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window